Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (27867)	2/5/1999 3:00:00 PM
From: Dan O.	Read Replies (1) \| Respond to of 32384

$0.23 per share in either cash or LGND shares, if I remember.

To: WTDEC who wrote (27867)	2/5/1999 3:25:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Dow Jones has come out with their version of the ONTAK approval: biocognizance.com

To: WTDEC who wrote (27867)	2/5/1999 4:17:00 PM
From: Henry Niman	Read Replies (3) \| Respond to of 32384

Press release is out: biocognizance.com and drug will be available in a week. However, LGND needs to do some follow up safety tests, so I'm not sure that "final" approval has been received and I'm not sure that the 6 month clock for payment to SRGN shareholders has begun (and it may not begin for quite some time because of additional trials).